Revenue GrowthThe company's moderate revenue growth indicates a solid market position and ability to expand its customer base, supporting long-term business sustainability.

Cash Flow GenerationStrong cash flow growth enhances financial flexibility, allowing for reinvestment in R&D and strategic initiatives, crucial for long-term competitiveness.

Product DiversificationA diversified product portfolio reduces dependency on a single revenue stream, mitigating risks and enhancing resilience against market fluctuations.

Bears Say

High LeverageHigh leverage can limit financial flexibility and increase risk during economic downturns, potentially impacting long-term growth and stability.

Profitability ChallengesOngoing profitability issues may hinder the company's ability to reinvest in growth and innovation, affecting its competitive position over time.

Negative Return On EquityInefficient use of equity capital can undermine investor confidence and limit the company's ability to attract new investments, impacting future growth.

Pharmarise Holdings Corp. News

Pharmarise Swings Back to Profit in First Half, Keeps Full-Year Outlook and Dividend Plan

Pharmarise Holdings Corp. ( ($JP:2796) ) just unveiled an announcement. Pharmarise Holdings reported consolidated net sales of ¥33.6...

1M ago

2796

Pharmarise Holdings Reports Strong Q1 Financial Performance

Pharmarise Holdings Corp. ( ($JP:2796) ) has issued an announcement. Pharmarise Holdings Corporation reported a significant increase in...

5M ago

2796

Pharmarise Holdings Reports Fiscal Year 2025 Financial Results

The latest update is out from Pharmarise Holdings Corp. ( ($JP:2796) ). Pharmarise Holdings Corporation reported its consolidated...

8M ago

2796

Pharmarise Holdings Reports Increased Sales but Faces Profit Challenges

Pharmarise Holdings Corp. ( ($JP:2796) ) has issued an update. Pharmarise Holdings Corporation reported a significant increase in...

11M ago

2796

Pharmarise Holdings Faces Profitability Challenges

Pharmarise Holdings Corp. (JP:2796) has released an update. Pharmarise Holdings Corp. reports a 13.1% increase in net sales...

1y ago

2796

Pharmarise Holdings Faces Profit Decline, Eyes Recovery

Pharmarise Holdings Corp. (JP:2796) has released an update. Pharmarise Holdings Corp. reports a slight increase in net sales...

2y ago

2796

2796 FAQ

What was Pharmarise Holdings Corp.’s price range in the past 12 months?

Pharmarise Holdings Corp. lowest stock price was ¥456.00 and its highest was ¥567.00 in the past 12 months.

What is Pharmarise Holdings Corp.’s market cap?

Pharmarise Holdings Corp.’s market cap is ¥6.08B.

When is Pharmarise Holdings Corp.’s upcoming earnings report date?

Pharmarise Holdings Corp.’s upcoming earnings report date is Apr 01, 2026 which is in 40 days.

How were Pharmarise Holdings Corp.’s earnings last quarter?

Pharmarise Holdings Corp. released its earnings results on Dec 25, 2025. The company reported ¥11.37 earnings per share for the quarter, beating the consensus estimate of N/A by ¥11.37.

Is Pharmarise Holdings Corp. overvalued?

According to Wall Street analysts Pharmarise Holdings Corp.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Pharmarise Holdings Corp. pay dividends?

Pharmarise Holdings Corp. pays a Annually dividend of ¥14 which represents an annual dividend yield of 2.65%. See more information on Pharmarise Holdings Corp. dividends here

What is Pharmarise Holdings Corp.’s EPS estimate?

Pharmarise Holdings Corp.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Pharmarise Holdings Corp. have?

Pharmarise Holdings Corp. has 12,060,381 shares outstanding.

What happened to Pharmarise Holdings Corp.’s price movement after its last earnings report?

Pharmarise Holdings Corp. reported an EPS of ¥11.37 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.695%.

Which hedge fund is a major shareholder of Pharmarise Holdings Corp.?

Currently, no hedge funds are holding shares in JP:2796

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Pharmarise Holdings Corp.

Pharmarise Holdings Corporation manages dispensing pharmacies in Japan. Its dispensing pharmacies provide patients with dispensing services based on prescriptions drawn up by medical institutions. The company also manages drug stores and convenience stores; and sells cosmetics. In addition, it is involved in the storage and management of medical examination records of patients on behalf of medical institutions; operation of medical mall; and provision of temporary help. As of May 31, 2021, the company operated 347 stores. Pharmarise Holdings Corporation was incorporated in 1984 and is headquartered in Tokyo, Japan.